作为PTPN2/PTPN1抑制剂的阿泽含衍生物的合成和结构-活性优化
Jiamin Zheng1, Zhisen Zhang1, Xiaoyu Ding1
1Insilico Medicine Shanghai Ltd, Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District, Shanghai, 201203, China.
European journal of medicinal chemistry
|April 11, 2024
概括
我们开发了化合物4,一种新型的小分子抑制剂,向蛋白铁酸酸酶N2和N1 (PTPN2/N1). 这种抑制剂显示出强烈的效能和疗效,为增强T细胞抗瘤免疫力提供了有前途的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 蛋白氨酸酸酶 (PTPNs),包括PTPN2和PTPN1 (PTP1B),在免疫细胞信号通路中发挥关键作用.
- 抑制PTPN2和PTPN1是增强T细胞介导抗瘤免疫力的有希望的策略.
- 现有的PTPN2/N1小分子抑制剂已进入临床试验阶段.
研究的目的:
- 设计和开发一种针对PTPN2和PTPN1的新型小分子抑制剂.
- 为了评估开发的化合物的抑制功效,药理动力学特性,以及体内抗瘤功效.
- 探索癌症免疫治疗的新治疗途径.
主要方法:
- 小分子抑制剂的设计和合成.
- 在体外酶测试以确定抑制功效 (纳米级范围).
- 在体内研究以评估口服生物可用性和抗瘤功效.
主要成果:
- 化合物4证明了对PTPN2和PTPN1的纳米分子抑制作用.
- 该化合物在体内表现出良好的口服生物利用性.
- 化合物4在临床前模型中显示出强大的抗瘤疗效.
结论:
- 化合物4是一种强大的,口服生物可用的PTPN2/N1.1.的小分子抑制剂.
- 这种新型抑制剂在体内已显示出显著的抗瘤疗效.
- 用化合物4准PTPN2/N1代表了增强T细胞抗瘤免疫力的有希望的策略.
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Preparation of 1° Amines: Azide Synthesis
3.9K
Direct alkylation of ammonia produces polyalkylated amines, along with a quaternary ammonium salt. To exclusively prepare primary amines, the azide synthesis method can be used.
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
3.9K
Structure-Activity Relationships and Drug Design
710
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
710
Basicity of Heterocyclic Aromatic Amines
6.0K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.0K


